description Merck & Co. (MRK) Overview
Merck & Co. (MRK), a global biopharmaceutical company, generates revenue primarily through the development, manufacturing, and marketing of prescription medicines, vaccines, and animal health products, consistently paying dividends to shareholders since its inception.
help Merck & Co. (MRK) FAQ
Why is Keytruda so important to Merck stockholders?
Keytruda, Merck's anti-PD-1 cancer therapy, is the company's largest product and accounted for roughly 46% of its 2024 revenue. That concentration makes Keytruda growth and its approaching patent transition central risks for MRK investors.
What businesses does Merck own besides Keytruda?
Merck also sells Gardasil 9, hospital and cardiovascular medicines, and veterinary products through Merck Animal Health. The animal-health unit gives the company exposure to livestock and companion-animal markets.
How often does Merck pay its dividend?
Merck normally pays cash dividends quarterly, subject to approval by its board. Investors should verify the latest declared amount and ex-dividend date through Merck's investor-relations materials before trading.
What is the biggest long-term risk to Merck's dividend?
The major business risk is Merck's dependence on Keytruda as important patent protections approach expiration later in the decade. Pipeline drugs, acquisitions, and newer formulations must help replace that revenue while still funding research and shareholder payments.
explore Explore More
Reviews & Comments
Write a Review
Be the first to review
Share your thoughts with the community and help others make better decisions.
